News

Renal & Urology News7y
FDA Approves Mirabegron Solifenacin Combo for OAB
The Food and Drug Administration (FDA) has approved Myrbetriq (mirabegron extended-release tablets; Astellas) in combination with the muscarinic antagonist solifenacin succinate for the treatment ...
Monthly Prescribing Reference7y
FDA Approves Myrbetriq Combo Treatment for Overactive Bladder
The Food and Drug Administration (FDA) has approved Myrbetriq (mirabegron extended-release tablets; Astellas) in combination with the muscarinic antagonist solifenacin succinate for the treatment ...
Medical Xpress5y
VESIcare LS approved for neurogenic detrusor overactivity
VESIcare (solifenacin succinate) tablets were approved in 2004 to treat overactive bladder in patients 18 years and older. VESIcare LS is the first FDA-approved treatment for NDO in patients as ...
Well+Good2mon
Check Your Medication Cabinets—Nearly 40 Generic Drugs Were Just Recalled, and You Might Have Some of Them
60-count bottle Solifenacin succinate tablets 10 mg, 30-count bottle and 90-count bottle Voriconazole tablets 200 mg, 30-count bottle Voriconazole tablets 50 mg, 30-count bottle Gabapentin tablets ...
Business Insider6y
MSN Labs/Novadoz Pharmaceuticals receives consecutive FDA approvals for their generic versions of Solifenacin and Trientine
The company was granted FDA approval to market Solifenacin Succinate tablets, their generic version of Astellas Pharma's product VesiCare©, on May 20 th. MSN also received FDA clearance to market ...
Business Insider5y
FDA Approves VESIcare LS™ (solifenacin succinate) Oral Suspension for Pediatric Patients
VESIcare (solifenacin succinate) tablets were initially approved in the United States in 2004. VESIcare LS oral suspension will come in a 5 mg/5 mL (1 mg/mL) oral suspension and will be available ...